1990
DOI: 10.1016/0002-9378(90)90552-i
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0
1

Year Published

1992
1992
2011
2011

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(20 citation statements)
references
References 13 publications
1
18
0
1
Order By: Relevance
“…The mean t 1/2 value of NGMN observed in this study is similar to that reported with norgestimate-containing oral contraceptives. 12 The similar t 1/2 value for NGMN between the patch and norgestimate-containing oral contraceptives is consistent with simple absorption and metabolism through the gastrointestinal tract and liver (in the case of oral contraceptives) and through the skin (in the case of the patch). There is no evidence to support a greater depot effect of the skin than of the gastric mucosa following patch delivery of these hormones.…”
Section: Norelgestromin and Ethinyl Estradiolsupporting
confidence: 65%
See 1 more Smart Citation
“…The mean t 1/2 value of NGMN observed in this study is similar to that reported with norgestimate-containing oral contraceptives. 12 The similar t 1/2 value for NGMN between the patch and norgestimate-containing oral contraceptives is consistent with simple absorption and metabolism through the gastrointestinal tract and liver (in the case of oral contraceptives) and through the skin (in the case of the patch). There is no evidence to support a greater depot effect of the skin than of the gastric mucosa following patch delivery of these hormones.…”
Section: Norelgestromin and Ethinyl Estradiolsupporting
confidence: 65%
“…Subjects were admitted to the study unit the evening prior to dosing on day 1 through the morning of day 2, from the morning of day 8 through the morning of day 9, and from the morning of day 18 through the last blood draw on day 20. Subjects visited the study unit on days 3, 4, 7, 10, 11,12,13,14,15,16, and 17 for pharmacokinetic and safety evaluations.…”
Section: Methodsmentioning
confidence: 99%
“…Norgestimate is rapidly metabolized after oral administration, and concentrations in human serum are typically low. The major metabolite, 17‐deacetyl norgestimate, has a pharmacological profile similar to that of norgestimate, and contributes to its pharmacological activity 13 . The AUC of 17‐deacetyl norgestimate was reduced by 12% after administration of OC plus alitretinoin, compared with OC alone.…”
Section: Discussionmentioning
confidence: 99%
“…5 Norgestimate is a prodrug: following oral administration, it is rapidly absorbed and almost completely converted to levonorgestrel-3-oxime (norelgestromin) and other progestationally active metabolites (including levonorgestrel) within 5 hours postdose. 48 The progestational activity of desogestrel is mediated by its metabolite, etonogestrel. 49 Unlike progesterone, etonogestrel has no glucocorticoid-like activity and does not bind to the MR. 20 Gestodene is absorbed without modification.…”
Section: Levonorgestrelmentioning
confidence: 99%